CoChat

Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank

Ung, Chuin Y., Warwick, Alasdair, Onoufriadis, Alexandros, Barker, Jonathan N., Parsons, Maddy, McGrath, John A., Shaw, Tanya J., Dand, Nick · 2023 · JAMA Dermatology
Cited by 66

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Importance: Keloids and hypertrophic scars (excessive scarring) are relatively understudied disfiguring chronic skin conditions with high treatment resistance. Objective: To evaluate established comorbidities of excessive scarring in European individuals, with comparisons across ethnic groups, and to identify novel comorbidities via a phenome-wide association study (PheWAS). Design, Setting, and Participants: This multicenter cross-sectional population-based cohort study used UK Biobank (UKB) data and fitted logistic regression models for testing associations between excessive scarring and a variety of outcomes, including previously studied comorbidities and 1518 systematically defined disease categories. Additional modeling was performed within subgroups of participants defined by self-reported ethnicity (as defined in UK Biobank). Of 502 701 UKB participants, analyses were restricted to 230078 individuals with linked primary care records. Exposures: Keloid or hypertrophic scar diagnoses. Main Outcomes and Measures: Previously studied disease associations (hypertension, uterine leiomyoma, vitamin D deficiency, atopic eczema) and phenotypes defined in the PheWAS Catalog. Results: Of the 972 people with excessive scarring, there was a higher proportion of female participants compared with the 229 106 controls (65% vs 55%) and a lower proportion of White ethnicity (86% vs 95%); mean (SD) age of the total cohort was 64 (8) years. Associations were identified with hypertension and atopic eczema in models accounting for age, sex, and ethnicity, and the association with atopic eczema (odds ratio [OR], 1.68; 95% CI, 1.36-2.07; P < .001) remained statistically significant after accounting for additional potential confounders. Fully adjusted analyses within ethnic groups revealed associations with hypertension in Black participants (OR, 2.05; 95% CI, 1.13-3.72; P = .02) and with vitamin D deficiency in Asian participants (OR, 2.24; 95% CI, 1.26-3.97; P = .006). The association with uterine leiomyoma was borderline significant in Black women (OR, 1.93; 95% CI, 1.00-3.71; P = .05), whereas the association with atopic eczema was significant in White participants (OR, 1.68; 95% CI, 1.34-2.12; P < .001) and showed a similar trend in Asian (OR, 2.17; 95% CI, 1.01-4.67; P = .048) and Black participants (OR, 1.89; 95% CI, 0.83-4.28; P = .13). The PheWAS identified 110 significant associations across disease systems; of the nondermatological, musculoskeletal disease and pain symptoms were prominent. Conclusions and Relevance: This cross-sectional study validated comorbidities of excessive scarring in UKB with comprehensive coverage of health outcomes. It also documented additional phenome-wide associations that will serve as a reference for future studies to investigate common underlying pathophysiologic mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamadermatol.2022.5607

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Macarak, 2021, Keloid disorder: fibroblast differentiation and gene expression profile in fibrotic skin diseases., Exp Dermatol, 30, 132, 10.1111/exd.v30.1 · doi:10.1111/exd.v30.1
  2. Uitto, 2007, IL-6 signaling pathway in keloids: a target for pharmacologic intervention?, J Invest Dermatol, 127, 6, 10.1038/sj.jid.5700604 · DOI
  3. Tan, 1993, Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor., Exp Cell Res, 209, 200, 10.1006/excr.1993.1302 · doi:10.1006/excr.1993.1302
  4. Limandjaja, 2021, Hypertrophic scars and keloids: overview of the evidence and practical guide for differentiating between these abnormal scars., Exp Dermatol, 30, 146, 10.1111/exd.v30.1 · doi:10.1111/exd.v30.1
  5. Uitto, 2020, Clinical challenge and call for research on keloid disorder: meeting report from the 3rd International Keloid Research Foundation Symposium, Beijing 2019., J Invest Dermatol, 140, 515, 10.1016/j.jid.2019.10.002 · DOI
  6. Bock, 2006, Quality of life of patients with keloid and hypertrophic scarring., Arch Dermatol Res, 297, 433, 10.1007/s00403-006-0651-7 · DOI · Paper page
  7. Trace, 2016, Keloids and hypertrophic scars: a spectrum of clinical challenges., Am J Clin Dermatol, 17, 201, 10.1007/s40257-016-0175-7 · DOI · Paper page
  8. González, 2019, Update on the treatment of scars., J Drugs Dermatol, 18, 550
  9. Cruz-Ávila, 2020, Comorbidity networks in cardiovascular diseases., Front Physiol, 11, 1009, 10.3389/fphys.2020.01009 · DOI
  10. Lu, 2021, Risk of cancer development in patients with keloids., Sci Rep, 11, 9390, 10.1038/s41598-021-88789-1 · DOI
  11. Kwon, 2021, The increased prevalence of keloids in atopic dermatitis patients with allergic comorbidities: a nationwide retrospective cohort study., Sci Rep, 11, 23669, 10.1038/s41598-021-03164-4 · DOI
  12. Lu, 2018, Keloid risk in patients with atopic dermatitis: a nationwide retrospective cohort study in Taiwan., BMJ Open, 8, 10.1136/bmjopen-2018-022865 · DOI
  13. Sun, 2014, Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study., Arch Dermatol Res, 306, 803, 10.1007/s00403-014-1491-5 · DOI
  14. El Hadidi, 2021, Does vitamin D deficiency predispose to keloids via dysregulation of koebnerisin (S100A15)? a case-control study., Wound Repair Regen, 29, 425, 10.1111/wrr.v29.3 · doi:10.1111/wrr.v29.3
  15. Yu, 2013, The TaqI gene polymorphisms of VDR and the circulating 1,25-dihydroxyvitamin D levels confer the risk for the keloid scarring in Chinese cohorts., Cell Physiol Biochem, 32, 39, 10.1159/000350121 · doi:10.1159/000350121
  16. Rutherford, 2017, A case-control study analyzing the association of keloids with hypertension and obesity., Int J Dermatol, 56, e187, 10.1111/ijd.2017.56.issue-9 · doi:10.1111/ijd.2017.56.issue-9
  17. Harmon, 2013, Keloids and ultrasound detected fibroids in young African American women., PLoS One, 8, 10.1371/journal.pone.0084737 · DOI
  18. Sudlow, 2015, UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age., PLoS Med, 12, 10.1371/journal.pmed.1001779 · DOI · Paper page
  19. Bozkurt, 2016, Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association., Circulation, 134, e535, 10.1161/CIR.0000000000000450 · DOI · Paper page
  20. Wei, 2017, Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record., PLoS One, 12, 10.1371/journal.pone.0175508 · DOI · Paper page
  21. van Buuren, 2011, Mice: multivariate imputation by chained equations in R., J Stat Softw, 45, 1, 10.18637/jss.v045.i03 · DOI · Paper page
  22. Stewart, 2017, Epidemiology of uterine fibroids: a systematic review., BJOG, 124, 1501, 10.1111/1471-0528.14640 · DOI · Paper page
  23. Qin, 2021, Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis., J Epidemiol Community Health, 75, 197, 10.1136/jech-2019-213364 · DOI
  24. Holick, 2011, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline., J Clin Endocrinol Metab, 96, 1911, 10.1210/jc.2011-0385 · DOI · Paper page
  25. Sohl, 2014, Prediction of vitamin D deficiency by simple patient characteristics., Am J Clin Nutr, 99, 1089, 10.3945/ajcn.113.076430 · DOI
  26. Nutten, 2015, Atopic dermatitis: global epidemiology and risk factors., Ann Nutr Metab, 66, 8, 10.1159/000370220 · DOI · Paper page
  27. Sjoberg, 2021, Reproducible summary tables with the gtsummary package., R J, 13, 570, 10.32614/RJ-2021-053 · DOI · Paper page
  28. Wickham, 2019, Welcome to the tidyverse., J Open Source Softw, 4, 1686, 10.21105/joss · DOI · Paper page
  29. Carroll, 2014, R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment., Bioinformatics, 30, 2375, 10.1093/bioinformatics/btu197 · DOI · Paper page
  30. Landau, 2021, The targets r package: a dynamic make-like function-oriented pipeline toolkit for reproducibility and high-performance computing., J Open Source Softw, 6, 2959, 10.21105/joss · DOI · Paper page
  31. Adotama, 2016, Association of keloids with systemic medical conditions: a retrospective analysis., Int J Dermatol, 55, e38, 10.1111/ijd.12969 · doi:10.1111/ijd.12969
  32. Snyder, 1996, Keloid associated with hypertension., Lancet, 347, 465, 10.1016/S0140-6736(96)90042-2 · DOI
  33. Williams, 2016, Hypertension treatment in Blacks: discussion of the US clinical practice guidelines., Prog Cardiovasc Dis, 59, 282, 10.1016/j.pcad.2016.09.004 · DOI
  34. Pavone, 2018, Epidemiology and risk factors of uterine fibroids., Best Pract Res Clin Obstet Gynaecol, 46, 3, 10.1016/j.bpobgyn.2017.09.004 · DOI · Paper page
  35. Dustan, 1995, Does keloid pathogenesis hold the key to understanding Black/White differences in hypertension severity?, Hypertension, 26, 858, 10.1161/01.HYP.26.6.858 · DOI
  36. Wu, 2020, RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17/Th22, and JAK3-skewing., Front Immunol, 11, 10.3389/fimmu.2020.597741 · DOI
  37. Maeda, 2019, Periostin is induced by IL-4/IL-13 in dermal fibroblasts and promotes RhoA/ROCK pathway-mediated TGF-ß1 secretion in abnormal scar formation., J Plast Surg Hand Surg, 53, 288, 10.1080/2000656X.2019.1612752 · DOI
  38. Nguyen, 2020, The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets., Arch Dermatol Res, 312, 81, 10.1007/s00403-019-01972-3 · DOI · Paper page
  39. Diaz, 2020, Keloid lesions show increased IL-4/IL-13 signaling and respond to Th2-targeting dupilumab therapy., J Eur Acad Dermatol Venereol, 34, e161, 10.1111/jdv.v34.4 · doi:10.1111/jdv.v34.4
  40. Wong, 2021, Dupilumab as an adjuvant treatment for keloid-associated symptoms., JAAD Case Rep, 13, 73, 10.1016/j.jdcr.2021.04.034 · doi:10.1016/j.jdcr.2021.04.034
  41. Warner, 2013, Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications., J Am Med Inform Assoc, 20, e281, 10.1136/amiajnl-2013-001861 · DOI
  42. Boland, 2013, Discovering medical conditions associated with periodontitis using linked electronic health records., J Clin Periodontol, 40, 474, 10.1111/jcpe.12086 · DOI
  43. Liao, 2013, Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls., Arthritis Rheum, 65, 571, 10.1002/art.37801 · DOI
  44. Zhang, 2020, Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity., Neurol Neuroimmunol Neuroinflamm, 7, 10.1212/NXI.0000000000000864 · DOI
  45. Moustafa, 1975, Presumptive evidence of the effect of pregnancy estrogens on keloid growth: case report., Plast Reconstr Surg, 56, 450, 10.1097/00006534-197510000-00019 · DOI
  46. Ibrahim, 2020, Adverse effects of pregnancy on keloids and hypertrophic scars., Cureus, 12, 10.7759/cureus.12154 · doi:10.7759/cureus.12154
  47. Noishiki, 2019, Sex differences in keloidogenesis: an analysis of 1659 keloid patients in Japan., Dermatol Ther (Heidelb), 9, 747, 10.1007/s13555-019-00327-0 · DOI
  48. Fong, 2002, Keloids—the sebum hypothesis revisited., Med Hypotheses, 58, 264, 10.1054/mehy.2001.1426 · DOI
  49. Limandjaja, 2020, The keloid disorder: heterogeneity, histopathology, mechanisms and models., Front Cell Dev Biol, 8, 360, 10.3389/fcell.2020.00360 · DOI · Paper page
  50. Yagi, 1979, Does an immune reaction to sebum in wounds cause keloid scars? beneficial effect of desensitisation., Br J Plast Surg, 32, 223, 10.1016/S0007-1226(79)90037-7 · DOI
  51. Vincent, 2008, Human skin keloid fibroblasts display bioenergetics of cancer cells., J Invest Dermatol, 128, 702, 10.1038/sj.jid.5701107 · DOI · Paper page
  52. Onoufriadis, 2018, Time series integrative analysis of RNA sequencing and microRNA expression data reveals key biologic wound healing pathways in keloid-prone individuals., J Invest Dermatol, 138, 2690, 10.1016/j.jid.2018.05.017 · DOI
  53. He, 2010, Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts., Br J Dermatol, 162, 538, 10.1111/j.1365-2133.2009.09511.x · DOI
  54. Koni, 2020, The Wnt signalling pathway: a tailored target in cancer., Int J Mol Sci, 21, 7697, 10.3390/ijms21207697 · DOI · Paper page
  55. Chaudet, 2020, Wnt signaling pathway proteins in scar, hypertrophic scar, and keloid: evidence for a continuum?, Am J Dermatopathol, 42, 842, 10.1097/DAD.0000000000001661 · DOI
  56. Driskell, 2015, Understanding fibroblast heterogeneity in the skin., Trends Cell Biol, 25, 92, 10.1016/j.tcb.2014.10.001 · DOI · Paper page
  57. Igota, 2013, Identification and characterization of Wnt signaling pathway in keloid pathogenesis., Int J Med Sci, 10, 344, 10.7150/ijms.5349 · DOI
  58. Barallobre-Barreiro, 2019, Cartilage-like composition of keloid scar extracellular matrix suggests fibroblast mis-differentiation in disease., Matrix Biol Plus, 4, 10.1016/j.mbplus.2019.100016 · DOI
  59. Clayton, 2020, Canonical and noncanonical TGF-ß signaling regulate fibrous tissue differentiation in the axial skeleton., Sci Rep, 10, 21364, 10.1038/s41598-020-78206-4 · DOI
  60. Wang, 2018, Aberrant TGF-ß activation in bone tendon insertion induces enthesopathy-like disease., J Clin Invest, 128, 846, 10.1172/JCI96186 · DOI
  61. Hawash, 2021, Pruritus in keloid scars: mechanisms and treatments., Acta Derm Venereol, 101, 10.2340/00015555-3923 · DOI
  62. Perrot, 2019, The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain., Pain, 160, 77, 10.1097/j.pain.0000000000001389 · DOI · Paper page
  63. Bayat, 2005, Keloid disease: clinical relevance of single versus multiple site scars., Br J Plast Surg, 58, 28, 10.1016/j.bjps.2004.04.024 · DOI · Paper page

Metadata

Authors
Ung, C. Y., Warwick, A., Onoufriadis, A., Barker, J. N., Parsons, M., McGrath, J. A., Shaw, T. J., & Dand, N.
Venue
JAMA Dermatology
Published
2023-02-01
Volume
159
Issue
2
Pages
172
ISSN
2168-6068
Cited by
66
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.